Literature DB >> 15561944

Endogenous ghrelin in pancreatic islets restricts insulin release by attenuating Ca2+ signaling in beta-cells: implication in the glycemic control in rodents.

Katsuya Dezaki1, Hiroshi Hosoda, Masafumi Kakei, Suzuko Hashiguchi, Masatomo Watanabe, Kenji Kangawa, Toshihiko Yada.   

Abstract

Ghrelin, isolated from the human and rat stomach, is the endogenous ligand for the growth hormone (GH) secretagogue receptor, which is expressed in a variety of tissues, including the pancreatic islets. It has been shown that low plasma ghrelin levels correlates with elevated fasting insulin levels and type 2 diabetes. Here we show a physiological role of endogenous ghrelin in the regulation of insulin release and blood glucose in rodents. Acylated ghrelin, the active form of the peptide, was detected in the pancreatic islets. Counteraction of endogenous ghrelin by intraperitoneal injection of specific GH secretagogue receptor antagonists markedly lowered fasting glucose concentrations, attenuated plasma glucose elevation, and enhanced insulin responses during the glucose tolerance test (GTT). Conversely, intraperitoneal exogenous ghrelin GH-independently elevated fasting glucose concentrations, enhanced plasma glucose elevation, and attenuated insulin responses during GTT. Neither GH secretagogue receptor antagonist nor ghrelin affected the profiles of the insulin tolerance test. In isolated islets, GH secretagogue receptor blockade and antiserum against acylated ghrelin markedly enhanced glucose-induced increases in insulin release and intracellular Ca2+ concentration ([Ca2+]i), whereas ghrelin at a relatively high concentration (10 nmol/l) suppressed insulin release. In single beta-cells, ghrelin attenuated glucose-induced first-phase and oscillatory [Ca2+]i increases via the GH secretagogue receptor and in a pertussis toxin-sensitive manner. Ghrelin also increased tetraethylammonium-sensitive delayed outward K+ currents in single beta-cells. These findings reveal that endogenous ghrelin in islets acts on beta-cells to restrict glucose-induced insulin release at least partly via attenuation of Ca2+ signaling, and that this insulinostatic action may be implicated in the upward control of blood glucose. This function of ghrelin, together with inducing GH release and feeding, suggests that ghrelin underlies the integrative regulation of energy homeostasis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15561944     DOI: 10.2337/diabetes.53.12.3142

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  117 in total

1.  Effectual comparison of quinoa and amaranth supplemented diets in controlling appetite; a biochemical study in rats.

Authors:  M V Mithila; Farhath Khanum
Journal:  J Food Sci Technol       Date:  2015-01-16       Impact factor: 2.701

Review 2.  The role of gut hormones in glucose homeostasis.

Authors:  Daniel J Drucker
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

3.  In search of an effective obesity treatment: a shot in the dark or a shot in the arm?

Authors:  Jeffrey M Zigman; Joel K Elmquist
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-21       Impact factor: 11.205

Review 4.  Gut hormones ghrelin, PYY, and GLP-1 in the regulation of energy balance [corrected] and metabolism.

Authors:  Diego Perez-Tilve; Ruben Nogueiras; Federico Mallo; Stephen C Benoit; Matthias Tschoep
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

5.  Mice lacking ghrelin receptors resist the development of diet-induced obesity.

Authors:  Jeffrey M Zigman; Yoshihide Nakano; Roberto Coppari; Nina Balthasar; Jacob N Marcus; Charlotte E Lee; Juli E Jones; Amy E Deysher; Amanda R Waxman; Ryan D White; Todd D Williams; Jennifer L Lachey; Randy J Seeley; Bradford B Lowell; Joel K Elmquist
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

6.  Expression of ghrelin receptor mRNA in the rat and the mouse brain.

Authors:  Jeffrey M Zigman; Juli E Jones; Charlotte E Lee; Clifford B Saper; Joel K Elmquist
Journal:  J Comp Neurol       Date:  2006-01-20       Impact factor: 3.215

7.  The continuous infusion of acylated ghrelin enhances growth hormone secretion and worsens glucose metabolism in humans.

Authors:  F Broglio; F Prodam; F Riganti; C Gottero; S Destefanis; R Granata; G Muccioli; T Abribat; A J van der Lely; E Ghigo
Journal:  J Endocrinol Invest       Date:  2008-09       Impact factor: 4.256

8.  Chronic alcohol exposure alters circulating insulin and ghrelin levels: role of ghrelin in hepatic steatosis.

Authors:  Karuna Rasineni; Paul G Thomes; Jacy L Kubik; Edward N Harris; Kusum K Kharbanda; Carol A Casey
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-01-31       Impact factor: 4.052

9.  Long-term treatment with the ghrelin receptor antagonist [d-Lys3]-GHRP-6 does not improve glucose homeostasis in nonobese diabetic MKR mice.

Authors:  Rasha Mosa; Lili Huang; Hongzhuo Li; Michael Grist; Derek LeRoith; Chen Chen
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-09-13       Impact factor: 3.619

10.  Effect of selective cyclooxygenase-2 (COX-2) inhibitor treatment on glucose-stimulated insulin secretion in C57BL/6 mice.

Authors:  Hiroki Fujita; Masafumi Kakei; Hiromi Fujishima; Tsukasa Morii; Yuichiro Yamada; Zhonghua Qi; Matthew D Breyer
Journal:  Biochem Biophys Res Commun       Date:  2007-08-27       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.